Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia

2023年 3月 20日

Read More

Zai Lab Statement on Silicon Valley Bank (“SVB”) and Joint US Federal Agency Announcement

2023年 3月 12日

Read More

Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates

2023年 3月 01日

Read More

Zai Lab Announces Participation in March Investor Conferences

2023年 2月 28日

Read More

Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress

2023年 2月 22日

Read More

Zai Lab Announces NDA Acceptance of Sulbactam-Durlobactam (SUL-DUR) for Infections Caused by Acinetobacter baumannii in China by the NMPA

2023年 2月 22日

Read More

Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023

2023年 2月 09日

Read More

Zai Lab Announces Participation in February Investor Conferences

2023年 1月 31日

Read More